Read the receipt.
- Displayed amount
- $135 /mo after intro
- Delivery route
- Nasal
- Product status
- Compounded prescription
- Membership in this figure
- See provider inclusions and terms
- Quantity
- Confirm the exact supplied quantity
- Upfront commitment
- Confirm the initial charge and billing period
Confirm taxes, diagnostics and any costs not specified in the quote.
Sources: Eden — NAD+ plans and inclusions, FDA — compounding questions and answers
What this price means.
The recurring monthly option is the cleaner comparison when avoiding a longer upfront term. It is still a different delivery route from an injection. Ask about concentration, bottle volume, storage and the exact renewal charge; the price page does not demonstrate a cognitive or energy benefit.
Sources: Eden — NAD+ plans and inclusions, FDA — compounding questions and answers
The product context.
Biological roles for NAD+ do not establish that buying an injectable or nasal preparation improves longevity or fatigue. FDA has received adverse-event reports involving NAD+ injectable drugs and has warned compounders about unsuitable ingredients for sterile preparations. Those reports are not findings about the individual providers on this board.
Sources: FDA — ingredients for sterile compounding, FDA — compounding questions and answers
Before you pay.
What will actually be charged today?
Confirm the initial charge and billing period. Request the full amount due today, its supply period, the next charge date and the renewal amount. The displayed price is a sourced offer, not a personalized invoice.
Is this a clinical recommendation?
No. This review covers public product and price information. Eligibility, treatment choice and the prescribed amount require an appropriate clinician. We have not tested this product.
What should I compare it with?
Start with the same ingredient, route, supplied quantity and billing term. Add any separate care or membership fees. Differences in product approval or formulation remain meaningful even when prices are similar.
Follow the evidence
Sources & price notes
Checked October 8, 2026. Provider pages document advertised terms; they do not independently establish clinical outcomes.
- Eden — NAD+ plans and inclusions ↗
Official public information; price and terms checked October 8, 2026.
- FDA — compounding questions and answers ↗
Clinical and regulatory context. A compounded preparation is not FDA-approved.
- FDA — ingredients for sterile compounding ↗
NAD+ adverse-event reports and ingredient-quality concerns; not a finding about any listed provider.